The combination of proguanil and atovaquone has been shown to be more
effective in curing drug-resistant infections of falciparum malaria th
an atovaquone or proguanil alone. Our current study sought to determin
e whether the antimalarial activity could be increased by adding dapso
ne. Plasma samples, obtained from individuals 4-72 h after proguanil-a
tovaquone administration, were 2-3 times more active against Plasmodiu
m falciparum in vitro when dapsone was added to them. The enhanced act
ivity of the combination of proguanil, atovaquone and dapsone is proba
bly due to the combined activity of two synergistic combinations: prog
uanil-atovaquone and cycloguanil (metabolite of proguanil)-dapsone. Th
ese findings suggest that further studies are needed to evaluate the c
linical value of the triple drug combination of proguanil, atovaquone
and dapsone in the treatment of multidrug resistant malaria. (C) 1997
Elsevier Science B.V.